Shanghai RAAS Blood Products
002252.SZ
#3291
Rank
C$6.59 B
Marketcap
C$1.00
Share price
-1.06%
Change (1 day)
-25.63%
Change (1 year)
Categories

Earnings for Shanghai RAAS Blood Products (002252.SZ)

Earnings in 2026 (TTM): C$0.29 Billion

According to Shanghai RAAS Blood Products's latest financial reports the company's current earnings are C$0.90 Billion. In 2024 the company made an earning of C$0.52 Billion, an increase over its 2023 earnings that were of C$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Shanghai RAAS Blood Products from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.29 B
2024 C$0.52 B16.84%
2023 C$0.44 B-7.63%
2022 C$0.48 B42.24%
2021 C$0.33 B10.74%
2020 C$0.30 B101.27%
2019 C$0.15 B-127.19%
2018 -C$0.57 Billion-265.98%
2017 C$0.33 B-29.79%
2016 C$0.48 B-12.28%
2015 C$0.54 B278.74%
2014 C$0.14 B241.48%
2013 C$42.4 M-27.95%
2012 C$58.84 M11.6%
2011 C$52.73 M10.64%
2010 C$47.66 M40.24%
2009 C$33.98 M31.73%
2008 C$25.79 M33.29%
2007 C$19.35 M